Ghana has strengthened its medicines regulatory system to ensure safety, quality and effectiveness of medical products manufactured, imported or distributed within the country, the World Health Organization (WHO) announced today.
Ghana becomes the second country in the WHO African Region to attain regulatory system Maturity Level 3 the second highest in the four tiered WHO classification of national medicines regulatory systems. Evaluations of Ghana Food and Drugs Authority the national regulatory body for medicines were carried out in 2014, 2015 and 2019 through the WHO Global Benchmarking Tool.
The FDA exist to ensure the safety, quality and efficacy of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances and clinical trials, and the control of tobacco products through the enforcement of relevant standards to protect public health.